# The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipients

> **NCT03558373** · — · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 158 (actual)

## Conditions studied

- Kidney Transplant

## Interventions

- **DRUG:** Immunosuppressive

## Key facts

- **NCT ID:** NCT03558373
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-31
- **Primary completion:** 2020-02-26
- **Final completion:** 2020-02-26
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2022-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03558373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03558373, "The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipients". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03558373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*